Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
Fuqiang Cui, Lipin Shen, Li Li, Huaqing Wang, Fuzhen Wang, Shengli Bi, Jianhua Liu, Guomin Zhang, Feng Wang, Hui Zheng, Xiaojin Sun, Ning Miao
Read Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China by Fuqiang Cui, Lipin Shen, Li Li, Huaqing Wang, Fuzhen Wang, Shengli Bi, Jianhua Liu, Guomin Zhang, Feng Wang, Hui Zheng, Xiaojin Sun, Ning Miao in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5403029.txt.
Description
Fuqiang Cui and eleven co-authors report on China's fight against hepatitis B in a paper in Emerging Infectious Diseases. Hepatitis B can settle into a chronic infection that leads to liver scarring and cancer. China once carried a huge share of the world's cases, with about one in ten people showing the virus marker in early surveys. The report weighs three national blood surveys against three decades of rising vaccine policy.
The marker rate fell by about half between the 1992 survey, taken before the modern vaccine era, and a 2014 survey. Among children under five, the fall was near total. Free infant shots and steps to block spread from mother to child drove the gain. The authors warn the work must hold for decades, with stronger steps to end spread.
Catalog record
| CREATOR | Fuqiang Cui, Lipin Shen, Li Li, Huaqing Wang, Fuzhen Wang, Shengli Bi, Jianhua Liu, Guomin Zhang, Feng Wang, Hui Zheng, Xiaojin Sun, Ning Miao |
|---|---|
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |